Tag: market competition

May 10, 2018

3D Signatures Strengthens Its Intellectual Property With New Patents Issued for Tests in Alzheimer’s Disease, Hodgkin’s Lymphoma and Multiple Myeloma

3D Signatures Inc. (TSXV:DXD,OTCQB:TDSGF), a personalized medicine company with a proprietary software platform (TeloViewTM) based on the three-dimensional analysis of...
April 3, 2018

Top Lithium Producer Tianqi Meets with Chilean Regulators on SQM Stake

Chinese lithium producer Tianqi met with Chile's anti-trust prosecutor weeks after Corfo filed a complaint to block the miner from...
April 3, 2018

3D Signatures Inc. Announces Successful Scoring Model Development and Analytical Validation of the Telo-HL(TM) Test for Hodgkin’s Lymphoma

3D Signa­­­­­­tures Inc. (TSXV:DXD) (OTCQB:TDSGF) (FSE:3D0) is pleased to announce the successful and on-time development of the scoring model for...
March 28, 2018

3D Signatures Collaborates with MDxHealth to Evaluate Telo-PC™ Test in Prostate Cancer

3D Signatures Inc. (TSXV:DXD,OTCQB:TDSGF) (the “Company” or "3DS"), a personalized medicine company with a proprietary software platform (TeloViewTM) based on...
March 19, 2018

Will Chile Block SQM Sale to Chinese Lithium Firms?

Chile's new government has to decide whether to back a petition by Corfo to block the sale of a stake...
March 6, 2018

3D Signatures Inc. and l’Institut Universitaire de Cardiologie et de Pneumologie de Québec (IUCPQ) Announce Collaboration to Combine TeloView™ with Genome Sequence Analysis in Lung Cancer

3D Signatures Inc. (TSX-V:DXD) (OTCQB:TDSGF) (FSE:3D0) (the "Company" or "3DS"), a personalized medicine company with a proprietary software platform based...
March 1, 2018

3D Signatures Reports Quarter Ended December 31, 2017 Financial Results

3D Signatures Inc. (TSXV:DXD) (OTCQB:TDSGF) (FSE:3D0) (the "Company" or "3DS"), a personalized medicine company with a proprietary software platform based...